Department of Pharmacology and Toxicology, University of Arkansas for Medical Sciences, Little Rock, Arkansas 72205, USA.
Toxicol Sci. 2010 Jun;115(2):475-81. doi: 10.1093/toxsci/kfq058. Epub 2010 Feb 22.
Sepsis-induced acute kidney injury (AKI) is a complex disease characterized by generation of inducible nitric oxide synthase (iNOS)-derived reactive nitrogen species (RNS) by the renal tubular epithelium. While most in vitro models of sepsis use combinations of lipopolysaccharide and cytokines to simulate exposure to inflammatory mediators thought to play a role in sepsis, the relevance of these models is limited. To address the need for a model that more closely mimics the tubular microenvironment during sepsis, we developed an in vitro model where mIMCD-3 (murine tubular epithelial) cells are treated with media containing 5% serum collected from mice at 4 h after cecal ligation and puncture (CLP) or sham surgery (no sepsis). After exposure to CLP serum, induction of iNOS messenger RNA occurred and NO generation was significantly increased compared to sham. This increase was accompanied by increased RNS as measured by oxidation of 5-(and-6)-carboxy-2,7'-dichlorodihydrofluorescein diacetate (carboxy-H(2)DCF-DA) and 2-(3,6-diamino-9H-xanthen-9-yl)-benzoic acid, methyl ester (dihydrorhodamine 123) and moderate cytotoxicity in cells treated with CLP serum, similar to what is observed in mice subjected to CLP. Since iNOS has been shown to play an important role in sepsis-induced AKI, the iNOS inhibitor L-N(6)-(1-iminoethyl)-lysine (L-NIL) was tested in this in vitro model. L-NIL completely blocked NO generation, RNS generation, and cytotoxicity, similar to its effects in vivo. Therefore, this new in vitro model exhibits many of the characteristics observed in vivo, suggesting that it is a relevant model for studying the mechanism of sepsis-induced renal epithelial RNS generation and injury.
脓毒症诱导的急性肾损伤 (AKI) 是一种复杂的疾病,其特征是肾小管上皮产生诱导型一氧化氮合酶 (iNOS) 衍生的活性氮物质 (RNS)。虽然大多数脓毒症的体外模型使用脂多糖和细胞因子的组合来模拟被认为在脓毒症中起作用的炎症介质的暴露,但这些模型的相关性有限。为了解决更接近脓毒症期间小管微环境的模型需求,我们开发了一种体外模型,其中 mIMCD-3(鼠肾小管上皮)细胞用含有 5%血清的培养基处理,该血清来自结扎和穿刺盲肠 (CLP) 或假手术 (无脓毒症) 后 4 小时的小鼠。暴露于 CLP 血清后,iNOS 信使 RNA 的诱导发生,与假手术相比,NO 的产生显著增加。这种增加伴随着 RNS 的增加,如 5-(和-6)-羧基-2,7'-二氯二氢荧光素二乙酸酯 (carboxy-H(2)DCF-DA) 和 2-(3,6-二氨基-9H-吖啶-9-基)-苯甲酸,甲酯(二氢罗丹明 123)的氧化和用 CLP 血清处理的细胞中的中度细胞毒性来衡量,类似于在接受 CLP 的小鼠中观察到的。由于 iNOS 已被证明在脓毒症诱导的 AKI 中发挥重要作用,因此在该体外模型中测试了 iNOS 抑制剂 L-N(6)-(1-亚氨基乙基)-赖氨酸 (L-NIL)。L-NIL 完全阻断了 NO 的产生、RNS 的产生和细胞毒性,与体内的作用相似。因此,这种新的体外模型表现出许多体内观察到的特征,表明它是研究脓毒症诱导的肾上皮 RNS 产生和损伤机制的相关模型。